Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (805)
  • 2024 (1003)
  • 2023 (1166)
  • 2022 (1405)
  • 2021 (1030)
  • 2020 (875)
  • 2019 (939)
  • 2018 (840)
  • 2017 (910)
  • 2016 (877)
  • 2015 (921)
  • 2014 (843)
  • 2013 (839)
  • 2012 (302)
  • 2011 (846)
  • 2008 (10)
  • 2007 (18)
  • 2006 (23)
  • 2005 (23)
  • 2004 (13)
  • 2003 (23)

Subject

  • Drug Trafficking (1120)
  • Synthetic drugs (380)
  • Guns/Weapons (285)
  • OCDETF/Task Force (196)
  • Seizures (Drugs/Property) (176)
  • Guilty Plea (160)
  • Fake Pills (113)
  • Arrests/Convictions - Major (108)
  • Task Forces/Task Force Officers (105)
  • Overdose (102)
  • Major Law Enforcement Operation (91)
  • Prescription Drugs (86)
  • Pharmaceuticals/Pharmacists/Physicians (67)
  • Diversion Division (54)
  • Outreach/Drug Prevention (49)
  • Gangs (46)
  • Money Laundering (40)
  • Take Back Day (40)
  • HIDTA (30)
  • Press Conferences (25)
  • Public and Media Affairs - also see Congressional Affairs (25)
  • Prevention/Education - DEA websites GSAD, JTT etc (19)
  • Narcoterrorism (16)
  • Extraditions (11)
  • Dark Web- Internet Trafficking (7)
  • International/Foreign Operations (7)
  • Asset Forfeiture (6)
  • Fentanyl Awareness (6)
  • One Pill Can Kill (4)
  • Red Ribbon (4)
  • Intergovernmental Affairs (3)
  • Museum and Visitors Center (3)
  • Congressional Affairs (1)
  • Critical Incident (1)
  • Intelligence Division - Intelligence Products (1)
  • Terrorism (1)

Drug Name

  • Fentanyl (505)
  • Methamphetamine (418)
  • Cocaine (391)
  • Heroin (247)
  • Marijuana (Cannabis) (74)
  • Oxycodone (45)
  • Synthetic Opioids (29)
  • Opioids (21)
  • Hydromorphone (13)
  • Ecstasy/MDMA (7)
  • Benzodiazepines (4)
  • Amphetamines (3)
  • Morphine (3)
  • Synthetic Bath Salts or Designer Cathinones (3)
  • Ketamine (2)
  • Methadone (2)
  • Steroids (2)
  • Barbiturates (1)
  • K2/Spice (1)
  • Marijuana Concentrates (1)

Field Division

  • New England (470)
  • New York (276)
  • Houston (166)
  • St. Louis (159)
  • Chicago (126)
  • Washington, DC (118)
  • San Francisco (115)
  • Miami (105)
  • Atlanta (103)
  • Dallas (99)
  • Seattle (89)
  • New Jersey (85)
  • New Orleans (70)
  • Detroit (67)
  • El Paso (60)
  • Headquarters (55)
  • Phoenix (42)
  • Los Angeles (40)
  • San Diego (40)
  • Omaha (19)
  • Rocky Mountain (16)
  • Philadelphia (13)
  • Louisville (4)
  • Caribbean (3)
Clear All Results
PRESS RELEASE

McKesson Pays Record $150 Million Settlement For Failure To Report Suspicious Pharmaceutical Drug Orders Including Opioids

January 17, 2017
NEWARK, N.J. - - McKesson (McKesson), one of the nation’s largest distributors of pharmaceutical drugs, agreed to pay a record $150 million civil penalty for alleged violations of the Controlled Substances (CSA), Carl J. Kotowski, Special Agent-in-Charge of the DEA’s New Jersey Division and Paul J. Fishman, U.S. Attorney for...
January 17, 2017
PRESS RELEASE

McKesson Agrees To Pay Record $150 Million Settlement For Failure To Report Suspicious Orders Of Pharmaceutical Drugs

January 17, 2017
WASHINGTON - McKesson (McKesson), one of the nation’s largest distributors of pharmaceutical drugs, agreed to pay a record $150 million civil penalty for alleged violations of the Controlled Substances (CSA), the U.S. Drug Enforcement (DEA) announced today. The nationwide settlement requires McKesson to suspend sales of controlled substances from distribution...
January 17, 2017
PRESS RELEASE

McKesson Settlement: Pays $150 Million, Largest Fine In DEA History

January 17, 2017
DETROIT - McKesson (McKesson), one of the nation’s largest distributors of pharmaceutical drugs, agreed to pay a record $150 million civil penalty for alleged violations of the Controlled Substances (CSA). Special Agent-in-Charge Timothy J. Plancon of the DEA Detroit Field Division was joined in the announcement today by United State...
January 17, 2017
PRESS RELEASE

McKesson Settlement: Pays $150 Million, Largest Fine In DEA History

January 17, 2017
LEXINGTON, Ky. - Carlton S. Shier, IV, Acting United States Attorney for the Eastern District of Kentucky, and Timothy J. Plancon, Special Agent-in-Charge of the DEA Detroit Field Division, announced today that McKesson (McKesson), one of the nation’s largest distributors of pharmaceutical drugs, agreed to pay a record $150 million...
January 17, 2017
PRESS RELEASE

McKesson Agrees To Pay Record $150 Million Settlement For Failure To Report Suspicious Orders Of Pharmaceutical Drugs

January 17, 2017
WASHINGTON - McKesson (McKesson), one of the nation’s largest distributors of pharmaceutical drugs, agreed to pay a record $150 million civil penalty for alleged violations of the Controlled Substances (CSA), DEA Denver Division Special Agent in Charge Barbra Roach and Acting U.S. Attorney Bob Troyer announced today. “This agreement demonstrates...
January 17, 2017
PRESS RELEASE

Largest Settlement In DEA History: McKesson Pays $150 Million

January 17, 2017
JAN 17 - BOSTON, MA - McKesson Corporation, one of the nation’s largest distributors of pharmaceutical drugs to pharmacies and other health care providers agreed to pay a record $150 million civil penalty for alleged violations of the Controlled Substances (CSA), Michael J. Ferguson Special Agent in Charge of the...
January 17, 2017
PRESS RELEASE

Acting Administrator Chuck Rosenberg Meets With Drug Control Officials In China

January 13, 2017
WASHINGTON - At the invitation of the China Ministry of Public (MPS), the Drug Enforcement (DEA) Acting Administrator Chuck Rosenberg visited China this week to discuss issues of mutual concern and to build on DEA’s existing relationship with Chinese counter-narcotics law enforcement authorities. Rosenberg emphasized the increased cooperation between the...
January 13, 2017
PRESS RELEASE

Kentucky Man Faces Life In Prison After Convicted By Jury Of Distributing Fentanyl Resulting In Death

January 13, 2017
LEXINGTON, Ky. - A Lexington man faces life in prison after a jury convicted him of distributing fentanyl that resulted in the overdose death of a 37 year-old Fayette County, Kentucky, resident. On Thursday, January 12th, 2017, Joshua Donald Ewing, 28, was convicted of distribution of a controlled substance resulting...
January 13, 2017
PRESS RELEASE

Doctor Who Owned McAllen Medical Clinic In Dallas Pleads Guilty In Pill Mill Case

January 13, 2017
DALLAS - Dr. Richard Andrews, 64, of Dallas, who was an owner and the sole supervising physician at the McAllen Medical Clinic located on South Hampton in Dallas, appeared in federal court this afternoon before U.S. District Judge Sidney A. Fitzwater and pleaded guilty to two conspiracy offenses stemming from...
January 13, 2017
PRESS RELEASE

Georgia Resident Sentenced To Life In Federal Prison For Methamphetamine Conspiracy

January 13, 2017
CHATTANOOGA, Tenn. - On Jan. 12, 2017, James Hedelsky, 59, of Bartow County, Ga, was sentenced to serve life in prison by the Honorable Travis R. McDonough, U.S. District Judge. Following a September 2016 jury trial, Hedelsky was convicted of conspiracy to distribute and possess with the intent to distribute...
January 13, 2017
Showing 2281 - 2290 of 2315 results

Pagination

  • First page «
  • Previous page ‹
  • Page 224
  • Page 225
  • Page 226
  • Page 227
  • Page 228
  • Current page 229
  • Page 230
  • Page 231
  • Page 232
  • Next page ›
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster